Agnete Fredriksen

Agnete Fredriksen

Company: Vaccibody

Job title: President & Chief Scientific Officer


Vaccibody’s Clinical Study – The Importance of Different Vaccine Platforms, Neoepitope Selection & Clinical Trial design to Show Vaccine-induced Clinical Efficacy 8:40 am

• Exploring the contribution of TMB, heterogeneity and neoepitope quality parameters for successful outcomes • Which patient populations could benefit from a neoantigen vaccine? • What is the ideal combination strategy for neoantigen vaccines?Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.